Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sørgård M, Di Marzo V, Julius D, Högestätt ED.

Nature. 1999 Jul 29;400(6743):452-7.

PMID:
10440374
2.

Cardiovascular pharmacology of anandamide.

Högestätt ED, Zygmunt PM.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):343-51. Review.

PMID:
12052048
3.

Anandamide: some like it hot.

Di Marzo V, Bisogno T, De Petrocellis L.

Trends Pharmacol Sci. 2001 Jul;22(7):346-9. Review.

PMID:
11431028
4.

New perspectives on enigmatic vanilloid receptors.

Szallasi A, Di Marzo V.

Trends Neurosci. 2000 Oct;23(10):491-7. Review.

PMID:
11006466
5.

Cannabinoid modulation of sensory neurotransmission via cannabinoid and vanilloid receptors: roles in regulation of cardiovascular function.

Ralevic V, Kendall DA, Randall MD, Smart D.

Life Sci. 2002 Oct 18;71(22):2577-94. Review.

PMID:
12354577
6.

Possible mechanisms of cannabinoid-induced antinociception in the spinal cord.

Morisset V, Ahluwalia J, Nagy I, Urban L.

Eur J Pharmacol. 2001 Oct 19;429(1-3):93-100. Review.

PMID:
11698030
7.

Endocannabinoids and the gut.

Pinto L, Capasso R, Di Carlo G, Izzo AA.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):333-41. Review. Erratum in: Prostaglandins Leukot Essent Fatty Acids. 2002 Oct;67(4):275.

PMID:
12052047
8.

Anandamide and vanilloid TRPV1 receptors.

Ross RA.

Br J Pharmacol. 2003 Nov;140(5):790-801. Epub 2003 Sep 29. Review.

9.

Anandamide receptors.

Di Marzo V, De Petrocellis L, Fezza F, Ligresti A, Bisogno T.

Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):377-91. Review.

PMID:
12052051
10.

[Anandamide: an endogenous cannabinoid receptor agonist].

Ueda N.

Seikagaku. 1995 Aug;67(8):1036-40. Review. Japanese. No abstract available.

PMID:
7594870
11.

Endocannabinoids: a new class of vasoactive substances.

Randall MD, Kendall DA.

Trends Pharmacol Sci. 1998 Feb;19(2):55-8. Review.

PMID:
9550942
12.

Functional morphology and physiological properties of bronchopulmonary C-fiber afferents.

Lee LY, Shuei Lin Y, Gu Q, Chung E, Ho CY.

Anat Rec A Discov Mol Cell Evol Biol. 2003 Jan;270(1):17-24. Review.

13.

The gastrointestinal pharmacology of cannabinoids.

Izzo AA, Mascolo N, Capasso F.

Curr Opin Pharmacol. 2001 Dec;1(6):597-603. Review.

PMID:
11757815
14.

N-arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, and related lipid molecules in the nervous tissues.

Sugiura T, Kondo S, Sukagawa A, Tonegawa T, Nakane S, Yamashita A, Waku K.

J Lipid Mediat Cell Signal. 1996 Sep;14(1-3):51-6. Review.

PMID:
8906545
15.

Vanilloid (capsaicin) receptors in health and disease.

Szallasi A.

Am J Clin Pathol. 2002 Jul;118(1):110-21. Review.

PMID:
12109845
16.

2-Arachidonoylglycerol and the cannabinoid receptors.

Sugiura T, Waku K.

Chem Phys Lipids. 2000 Nov;108(1-2):89-106. Review.

PMID:
11106784
17.

[Influence of anandamide, the endogenous agonist of cannabinoid receptors on the circulatory system].

Kwolek G, Zakrzeska A, Kozłowska H, Malinowska B.

Postepy Hig Med Dosw (Online). 2005 May 19;59:208-18. Review. Polish.

18.

Endogenous lipids that activate cannabinoid receptors. Formation and inactivation.

Di Tomaso E, Cadas H, Gaillet S, Beltramo M, Desarnaud F, Venance L, Piomelli D.

Adv Exp Med Biol. 1997;407:335-40. Review. No abstract available.

PMID:
9321973
19.

Endovanilloid signaling in pain.

Di Marzo V, Blumberg PM, Szallasi A.

Curr Opin Neurobiol. 2002 Aug;12(4):372-9. Review.

PMID:
12139983
20.

[Anandamide and its related compounds].

Ueda N.

Tanpakushitsu Kakusan Koso. 1999 Jun;44(8 Suppl):1139-45. Review. Japanese. No abstract available.

PMID:
10396995

Supplemental Content

Support Center